Comparison of the effect of glutamate receptor modulators in the 6 Hz and maximal electroshock seizure models

Epilepsy Research

Volumn 56, Issue 1, 2003, Pages 17-26

  Barton, Matthew E ^a   Peters, Steven C ^a   Shannon, Harlan E ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Animal models; Glutamate; iGlu receptors; mGlu receptors

Indexed keywords

1 (4 AMINOPHENYL) 3,4 DIHYDRO 4 METHYL 3 METHYLCARBAMOYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 2 AMINO 4 PHOSPHONOBUTYRIC ACID; 2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; 4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; 4 AMINO 2 THIABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; 4 CARBOXY 2 METHYLPHENYLGLYCINE; 6 (4 CARBOXYBENZYL) 1,2,3,4,4A,5,6,7,8,8A DECAHYDRO 3 ISOQUINOLINECARBOXYLIC ACID; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; AMPA RECEPTOR ANTAGONIST; ANTICONVULSIVE AGENT; DECAHYDRO 6 PHOSPHONOMETHYL 3 ISOQUINOLINECARBOXYLIC ACID; DECAHYDRO 6 [2 (1H TETRAZOL 5 YL)ETHYL] 3 ISOQUINOLINECARBOXYLIC ACID; DIZOCILPINE; GLUTAMATE RECEPTOR ANTAGONIST; IONOTROPIC RECEPTOR ANTAGONIST; LY 377770; LY 456236; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; EXPERIMENTAL MODEL; EXPERIMENTAL TEST; FOCAL EPILEPSY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0141755379     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2003.08.001     Document Type: Article

References (33)

1. Barton M.E., Klein B.D., Wolf H.H., White H.S. Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy. Epilepsy Res. 47:2001;217-227.
2. Brown W.C., Schiffman D.O., Swinyard E.A., Goodman L.S. Comparative assay of antiepileptic drugs by "psychomotor" seizure test and minimal electroshock threshold test. J. Pharmacol. Exp. Ther. 107:1953;273-283.
3. Chapman A.G., Meldrum B.S. Non-competitive N-methyl-D-aspartate antagonists protect against sound-induced seizures in DBA/2 mice. Eur. J. Pharmacol. 166:1989;201-211.
4. Chapman A.G., Smith S.E., Meldrum B.S. The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466 in mice. Epilepsy Res. 9:1991;92-96.
5. Chapman A.G., Nanan K., Yip P., Meldrum B.S. Anticonvulsant activity of a metabotropic glutamate receptor 8 preferential agonist, (R,S)-4-phosphonophenylglycine. Eur. J. Pharmacol. 383:1999;23-27.
6. Chapman A.G., Nanan K., Williams M., Meldrum B.S. Anticonvulsant activity of two metabotropic glutamate Group I antagonists selective for the mGlu5 receptor 2-methyl-6-(phenylethynyl)-pyridine (MPEP), and (E)-6-methyl-2-styryl-pyridine (SIB 1893). Neuropharmacology. 39:2000;1567-1574.
7. Conn P.J., Pin J.P. Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 37:1997;205-237.
8. Dunham N.W., Miya T.S. A note on a simple apparatus for detecting neurological deficit in mice and rats. J. A. Pharm. Assoc. Sci. Ed. 46:1957;208-209.
9. During M.J., Spencer D.D. Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain. Lancet. 341:1993;1607-1610.
10. Finney, D.J., 1971. Probit Analysis. Cambridge Univeristy Press, Cambridge.
11. Fisher R.S., Cysyk B.J., Lesser R.P., Pontecorvo M.J., Ferkany J.T., Schwerdt P.R., Hart J., Gordon B. Dextromethorphan for treatment of complex partial seizures. Neurology. 40:1990;547-549.
12. Gasparini F., Bruno V., Battaglia G., Lukic S., Leonhardt T., Inderbitzin W., Laurie D., Sommer B., Varney M.A., Hess S.D., Johnson E.C., Kuhn R., Urwyler S., Sauer D., Portet C., Schmutz M., Nicoletti F., Flor P.J. (R,S)-4-Phosphonophenylglycine, a potent and selective Group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo. J. Pharmacol. Exp. Ther. 289:1999;1678-1687.
13. Herrling, P., Emre, M., Watkins, J., 1997. D-CPPene (SDZ EAA-494)-a competitive NMDA antagonist: pharmacology and results in humans. In: Excitatory Amino Acids - Clinical Results with Antagonists, p. 21.
14. Loscher W., Honack D. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine. J. Pharmacol. Exp. Ther. 256:1991;432-440.
15. Loscher W., Honack D. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil. Br. J. Pharmacol. 113:1994;1349-1357.
16. McBain C.J., Mayer M.L. N-methyl-D-aspartic acid receptor structure and function. Physiol. Rev. 74:1994;723-760.
17. Moldrich R.X., Jeffrey M., Talebi A., Beart P.M., Chapman A.G., Meldrum B.S. Anti-epileptic activity of Group II metabotropic glutamate receptor agonists (-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268) and (-)-2-thia-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY389795). Neuropharmacology. 41:2001;8-18.
18. Olney J.W., Rhee V., Ho O.L. Kainic acid: a powerful neurotoxic analogue of glutamate. Brain Res. 77:1974;507-512.
19. Palmer G.C., Harris E.W., Ray R., Stagnitto M.L., Schmiesing R.J. Classification of compounds for prevention of NMDLA-induced seizures/mortality, or maximal electroshock and pentylenetetrazol seizures in mice and antagonism of MK801 binding in vitro. Arch. Int. Pharmacodyn. Ther. 317:1992;16-34.
20. Pin J.P., Duvoisin R. The metabotropic glutamate receptors: structure and functions. Neuropharmacology. 34:1995;1-26.
21. Storm-Mathisen, J., Ottersen, O.P., 1989. Anatomy of putative glutamatergic neurons. In: Avoli, M., Reader, T.A., Dykes, R.W., Gloor, P. (Eds.), Neurotransmitters and Cortical Function. Plenum Press, New York, London.
22. Sveinbjornsdottir S., Sander J.W., Upton D., Thompson P.J., Patsalos P.N., Hirt D., Emre M., Lowe D., Duncan J.S. The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy. Epilepsy Res. 16:1993;165-174.
23. Swinyard EA (1972) Electrically induced seizures. In: Walter, R.D. (Ed.), Experimental Models of Epilepsy: A Manual for the Laboratory Worker. Raven Press, New York, pp. 433-458.
24. Tizzano J.P., Griffey K.I., Schoepp D.D. Induction or protection of limbic seizures in mice by mGluR subtype selective agonists. Neuropharmacology. 34:1995;1063-1067.
25. Toman J.E.P. Neuropharmacologic considerations inpsychic seizures. Neurology. 1:1951;444-460.
26. Toman J.E.P., Everett G.M., Richards R.K. The search for new drugs against epilepsy. Tex. Rep. Biol. Med. 10:1952;96-104.
27. Tricklebank M.D., Singh L., Oles R.J., Preston C., Iversen S.D. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Eur. J. Pharmacol. 167:1989;127-135.
28. Troupin, A., Mendius, J., Cheng, F., Risinger, M., 1986. MK-801. In: Meldrum, B.S., Porter, R.J., (Eds.), New Anticonvulsant Drugs: Current Problems in Epilepsy. John Libbey, London, pp. 191-201.
29. Turski W., Turski L., Czuczwar S.J., Kleinrok Z. (RS)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid: wet dog shakes, catalepsy and body temperature changes in rats. Pharmacol. Biochem. Behav. 15:1981;545-549.
30. White H.S., Johnson M., Wolf H.H., Kupferberg H.J. The early identification of anticonvulsant activity: role of the maximal electroshock and subcutaneous pentylenetetrazol seizure models. Ital. J. Neurol. Sci. 16:1995;73-77.
31. Woodbury D.M., Davenport V.D. Design and use of new electroshock seizure apparatus, and analysis of factors altering seizure threshold and pattern. Arch. Int. Pharmacodyn. Ther. 92:1952;97-104.
32. Yamaguchi S., Donevan S.D., Rogawski M.A. Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI 52466 and NBOX in maximal electroshock and chemoconvulsant seizure models. Epilepsy Res. 15:1993;179-184.
33. Zaczek R., Collins J., Coyle J.T. N-Methyl-D-aspartate acid: a convulsant with weak neurotoxic properties. Neurosci. Lett. 24:1981;181-186.